Clinical Trial

A Phase Ⅱ/Ⅲ Study of HRS-2129 for Postsurgical Pain Management in Abdominal Surgery

Recruiting Phase 2/3
View on ClinicalTrials.gov →
Record status
This record was last updated November 17, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a phase II/III, multi-center, randomized, double-blind, comparator-controlled study to evaluate the efficacy and safety of HRS-2129 for postoperative pain management in abdominal surgery.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-15.
Status change: Not Yet Recruiting → Recruiting 2025-11-13
Trial Details
NCT Number NCT07185594
Lead Sponsor Shandong Suncadia Medicine Co., Ltd.
Conditions Postoperative Analgesia
Enrollment 360 participants
Start Date 2025-10-24
Primary Completion 2025-12 (estimated)
Study Completion 2026-01 (estimated)
Updated on ClinicalTrials.gov 2025-11-17